Nasopharyngeal Carcinoma: all 824 studies
Page 2 of 9. Open to participants first (281), then studies with results posted, then the rest; newest registration first within each.
- Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP TrialRecruitingNCT06636734Phase 2
- Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal CarcinomaRecruitingNCT06611150Phase 1
- GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal CarcinomaNot yet recruitingNCT06605131Phase 2
- Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)RecruitingNCT06592599Phase 2
- Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal CarcinomaNot yet recruitingNCT06572293Not applicable
- TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT06561763Phase 3
- Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.RecruitingNCT06533267Not applicable
- Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerRecruitingNCT06532279Phase 2
- Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.RecruitingNCT06529562Not applicable
- Online Adaptive Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT06516133Phase 3
- Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaRecruitingNCT06509009Phase 2
- GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal CarcinomaNot yet recruitingNCT06490341Phase 2
- PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.Not yet recruitingNCT06486220Phase 3
- Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam TherapyNot yet recruitingNCT06480903
- [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck CancersRecruitingNCT06479811Phase 1
- A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsRecruitingNCT06475300Phase 2
- The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving RadiotherapyRecruitingNCT06472739Phase 2
- Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPCRecruitingNCT06472713Phase 2
- Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life StudyNot yet recruitingNCT06472024Not applicable
- Deep Learning-based sbORN Diagnostic ModelRecruitingNCT06463392
- GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06455410Phase 2
- Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal CarcinomaRecruitingNCT06445088
- Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 TrialRecruitingNCT06438627Phase 3
- Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC PatientsRecruitingNCT06389201Not applicable
- Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.RecruitingNCT06383780Phase 3
- A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid TumorsNot yet recruitingNCT06383507Phase 1
- KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical TrialNot yet recruitingNCT06370026Early Phase 1
- Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal CarcinomaNot yet recruitingNCT06364826Phase 2
- Artificial Intelligence-supported Reading Versus Standard Double Reading for the Interpretation of Magnetic Resonance Imaging in the Detection of Local Recurrence for Nasopharyngeal Carcinoma: a Randomised Controlled Multicenter StudyNot yet recruitingNCT06356441
- Adebrelimab and Chemoradiotherapy in High-risk LANPCRecruitingNCT06349889Phase 2
- Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT06331845Phase 2
- Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal CarcinomaNot yet recruitingNCT06328868Not applicable
- SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal CarcinomaRecruitingNCT06323239Phase 2
- Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal CarcinomaRecruitingNCT06321939
- De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06313450Not applicable
- A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal MucositisRecruitingNCT06308328
- Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral MucositisRecruitingNCT06307314
- Effect of Oral Enteral Nutrition in Nasopharyngeal Carcinoma Survivors With Swallowing DisordersNot yet recruitingNCT06301672Not applicable
- TPC Versus GP Induction Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06301165Phase 2
- A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal MucositisRecruitingNCT06287788
- Xerostomia-optimised IMRT Versus Standard IMRT in NPCRecruitingNCT06282497Not applicable
- Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal CarcinomaRecruitingNCT06277050Phase 3
- The Protection of Thyroid Function in IMRT for Nasopharyngeal CarcinomaRecruitingNCT06268600Not applicable
- Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal CarcinomaRecruitingNCT06265844Not applicable
- Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal CarcinomaRecruitingNCT06259721Phase 2
- Individualized Elective Neck Irradiation in NPC PatientsRecruitingNCT06241612Phase 3
- A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)RecruitingNCT06241599Phase 2/3
- Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment ResponseRecruitingNCT06239727Phase 3
- Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPCRecruitingNCT06235203Phase 3
- Adjuvant vs Surgery Only in Early-stage Recurrent NPCRecruitingNCT06228079Phase 3
- Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPCRecruitingNCT06197776
- The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPCRecruitingNCT06182657
- Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPCRecruitingNCT06177301Phase 3
- The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in NPC PatientsNot yet recruitingNCT06174012Phase 2
- Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated RadiotherapyRecruitingNCT06170021
- PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction ChemotherapyRecruitingNCT06156878Phase 2
- Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of LifeNot yet recruitingNCT06136962
- Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue ImagingNot yet recruitingNCT06129201
- KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical TrialRecruitingNCT06097793Early Phase 1
- Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPCNot yet recruitingNCT06095167Phase 3
- CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal CarcinomaRecruitingNCT06095154Phase 3
- Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaRecruitingNCT06093061Phase 2
- Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction ChemotherapyRecruitingNCT06092957Phase 3
- A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)RecruitingNCT06064097Phase 2
- Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.RecruitingNCT06059261Phase 2
- Prospective Observational Study to Predict Severe Oral Mucositis Associated With Chemoradiotherapy in Nasopharyngeal Carcinoma Based on Deep LearningRecruitingNCT06032767
- Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal CancerRecruitingNCT06029270Phase 2
- GNT Induction Treatment in Locally Advanced NPCRecruitingNCT06026878Phase 3
- Nivolumab in Children and Adults With Nasopharyngeal CarcinomaRecruitingNCT06019130Phase 2
- Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT06017895Not applicable
- Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal CarcinomaRecruitingNCT05994170Not applicable
- Anrotinib and Tirelizumab in First-line Treatment of RM-NPCRecruitingNCT05981157Phase 2
- A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsRecruitingNCT05956587Phase 2
- A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesRecruitingNCT05955105Phase 1/2
- A Retrospective Study Reveals the Relationship Between gp42-IgG Epitopes and EBV-associated NPCRecruitingNCT05949749
- IC Plus Low-dose Radiation Plus Cadonilimab in LANPCRecruitingNCT05941741Phase 3
- Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05913414Phase 2
- Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal CarcinomaNot yet recruitingNCT05912582
- Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT05898256Phase 1/2
- Bacterial Decolonization to Prevent Radiation-induced Oral MucositisRecruitingNCT05893810Phase 3
- Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After ChemoradiotherapyRecruitingNCT05892354Not applicable
- Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal CarcinomaRecruitingNCT05884983
- Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal CarcinomaRecruitingNCT05877872Phase 3
- Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT05860868Phase 3
- Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma PatientsRecruitingNCT05858385
- Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPCRecruitingNCT05854849Phase 3
- Cadonilimab (AK104) in the Treatment of Nasopharyngeal CarcinomaRecruitingNCT05790200Phase 2
- A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPCNot yet recruitingNCT05780294Phase 3
- Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant ChemotherapyRecruitingNCT05772208Phase 3
- Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver MetastasesRecruitingNCT05771025Not applicable
- Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal CarcinomaRecruitingNCT05717790Not applicable
- Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing TreatmentNot yet recruitingNCT05717764Phase 3
- Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaRecruitingNCT05707819
- Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant ChemotherpyRecruitingNCT05674305Phase 3
- EBV CAR-T Cells for Nasopharyngeal CarcinomaRecruitingNCT05654077Early Phase 1
- SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPCRecruitingNCT05652192Phase 2
- A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in ChinaRecruitingNCT05638269
- Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICTRecruitingNCT05628922Phase 2
- Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal CarcinomaRecruitingNCT05626829Phase 2
- A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and ChemotherapyNot yet recruitingNCT05622474Not applicable